Literature DB >> 8792421

Iontophoretic delivery of a telomeric oligonucleotide.

R M Brand1, P L Iversen.   

Abstract

PURPOSE: To evaluate the feasibility of iontophoretically enhanced transdermal delivery of a phosphorothioate oligonucleotide across hairless mouse skin.
METHODS: The phosphorothioate sequence, 5'-d(TTAGGG)-3' (TAG-6) which mimics the repeat sequence of the telomere was used as a model compound. Iontophoresis was performed on hairless mouse skin using as in vitro flow-through diffusion system. Both 5'-FITC and uniformly 35S labeled oligonucleotide were used to monitor transdermal flux.
RESULTS: Cathodal delivery of TAG-6 resulted in substantial oligonucleotide flux. The molecular label did not alter transport properties. No flux was measured with either anodal or passive delivery. The oligonucleotide was not degraded as it crossed the skin. Molecular transport was donor condition dependent, with pH and salt concentration both having significant effects. Pre-treating the skin with ethanol reduced iontophoretic transport.
CONCLUSIONS: These data demonstrate that iontophoresis can enhance transdermal flux of an intact phosphorothioate oligonucleotide and that this penetration is donor condition dependent. Furthermore, iontophoretically enhanced transdermal delivery is a feasible approach to the administration of phosphorothioate oligonucleotides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792421     DOI: 10.1023/a:1016092809914

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery.

Authors:  V Srinivasan; W I Higuchi; S M Sims; A H Ghanem; C R Behl
Journal:  J Pharm Sci       Date:  1989-05       Impact factor: 3.534

2.  Transport mechanisms in iontophoresis. II. Electroosmotic flow and transference number measurements for hairless mouse skin.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

3.  Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.

Authors:  M J Pikal; S Shah
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

4.  A new system for in vitro studies of iontophoresis.

Authors:  P Glikfeld; C Cullander; R S Hinz; R H Guy
Journal:  Pharm Res       Date:  1988-07       Impact factor: 4.200

5.  Transdermal transport of DNA antisense oligonucleotides by electroporation.

Authors:  T E Zewert; U F Pliquett; R Langer; J C Weaver
Journal:  Biochem Biophys Res Commun       Date:  1995-07-17       Impact factor: 3.575

6.  Penetration of oligonucleotides into mouse organism through mucosa and skin.

Authors:  V V Vlassov; V N Karamyshev; L A Yakubov
Journal:  FEBS Lett       Date:  1993-08-02       Impact factor: 4.124

7.  The RNA component of human telomerase.

Authors:  J Feng; W D Funk; S S Wang; S L Weinrich; A A Avilion; C P Chiu; R R Adams; E Chang; R C Allsopp; J Yu
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

8.  Reaction between metabolically activated acetaminophen and phosphorothioate oligonucleotides.

Authors:  B L Copple; W M Gmeiner; P L Iversen
Journal:  Toxicol Appl Pharmacol       Date:  1995-07       Impact factor: 4.219

Review 9.  Oligonucleotide pharmacotherapy: an antigene strategy.

Authors:  K M Nagel; S G Holstad; K E Isenberg
Journal:  Pharmacotherapy       Date:  1993 May-Jun       Impact factor: 4.705

10.  Iontophoretic delivery of oligonucleotide derivatives into mouse tumor.

Authors:  V V Vlassov; M V Nechaeva; V N Karamyshev; L A Yakubov
Journal:  Antisense Res Dev       Date:  1994
View more
  3 in total

1.  Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Authors:  W Lin; M Cormier; A Samiee; A Griffin; B Johnson; C L Teng; G E Hardee; P E Daddona
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

2.  Localization of a FITC-labeled phosphorothioate oligodeoxynucleotide in the skin after topical delivery by iontophoresis and electroporation.

Authors:  V Regnier; V Préat
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

3.  Topical delivery of anti-sense oligonucleotides using low-frequency sonophoresis.

Authors:  Ahmet Tezel; Sujatha Dokka; Susan Kelly; Gregory E Hardee; Samir Mitragotri
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.